Name: JBIO Balance Sheet - Jade Biosciences Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

JBIO - Jade Biosciences, Inc.

USD | NASDAQ | Healthcare

JBIO Balance Sheet - Jade Biosciences Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Cash And Short Term Investments
Cash And Equivalents	88.4	69.4	23.5	22.4	54.2	4.6	-
Restricted Cash	-	-	-	-	-	-	-
Short Term Investments	247.7	0.0	98.9	106.8	113.2	-	-
Cash And Short Term Investments	336.2	69.4	122.4	129.2	167.4	4.6	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-
Prepaid Expenses	12.7	0.3	1.8	2.3	7.0	0.1	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-
Current Liabilities
Accounts Payable	2.2	1.3	2.4	2.6	1.2	0.6	-
Short Term Debt	-	-	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.7	0.0	0.3	0.7	0.4	-
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	-	-
Additional Paid In Capital	506.8	0.2	272.6	215.1	208.9	0.1
Supplementary Data
Total Debt	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19
Cash And Short Term Investments
Cash And Equivalents	55.1	88.4	50.1	220.9	44.2	-	31.1	31.1	9.1	23.5	32.2	60.9	26.6	22.4	22.4

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	7.2	12.7	2.5	2.0	1.2	-	1.9	6.6	3.9	1.8	2.4	2.4	1.6	2.3	2.6	1.5	4.8	7.0
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	318.5	348.8	201.4	223.0	77.4	-	90.6	110.8	103.2	124.2	137.6	152.5	120.6	131.5	145.2	153.4

Current Liabilities
Accounts Payable	4.0	2.2	1.4	7.6	0.1	-	0.9	4.2	3.3	2.4	3.5	5.5	4.7	2.6	4.5	2.1	2.9	1.2	2.6	-	-	0.6	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	-	-	-	-	0.3	-	0.5	0.5	0.4	0.4	0.5	0.4	0.4	0.4	0.4	0.3
Accrued Expenses	14.9	9.4	14.0	8.1	1.6	-	4.0	2.7	1.3	4.4	2.6	1.5	1.0	1.7	1.1	-	-	0.8
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	22.3	16.5	22.4	21.6	2.4	-	10.3	17.0	15.5	17.6	14.7	13.3	10.6	7.8	7.7	3.8

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.7	0.7	0.7	0.8	-	-	0.1	0.2	0.3	0.3	0.4	0.5	0.6	0.7	0.8	0.9
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	23.0	17.3	23.1	22.4	2.5	-	10.5	17.3	15.9	18.0	15.2	13.8	11.3	8.6	8.5	4.6

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-	-	-
Additional Paid In Capital	511.6	506.8	321.8	318.9	310.6	-	307.9	305.9	277.5	272.6	268.9	265.6	217.7	215.1	212.8	211.1	209.9
Retained Earnings	(214.8)	(174.4)	(142.5)	(117.3)	(235.6)	-	(227.6)	(211.4)	(186.6)	(163.4)	(143.0)	(123.4)	(104.4)	(87.9)	(72.9)	(59.3)	(47.3)
Accumulated Other Comprehensive Income	(0.3)	0.1	0.0	(0.0)	0.1	-	0.2	(0.1)	(0.0)	0.2	(0.2)	(0.2)	(0.2)	(0.5)	(0.8)	(0.8)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	296.5	332.5	179.3	201.6	(83.5)	0.0	(16.9)	(0.6)	90.9	109.5	125.7	141.9	113.1	126.7	139.1	151.1	161.9
Total Equity	296.5	332.5	179.3	201.6	(83.5)	0.0	(16.9)	(0.6)	90.9	109.5	125.7	141.9	113.1	126.7	139.1	151.1	161.9	172.4

Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Working Capital	296.2	332.3	179.0	201.4	75.0	-	80.3	93.7	87.7	106.6	122.9	139.2	109.9	123.7	137.5	149.7	161.2	171.8
Book Value	296.5	332.5	179.3	201.6	(83.5)	0.0	(16.9)	(0.6)	90.9	109.5	125.7	141.9	113.1	126.7	139.1	151.1	161.9	172.4
Tangible Book Value	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-